Johnson & Johnson [JNJ] stock is trading at $153.18, down -0.31%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The JNJ shares have gain 4.66% over the last week, with a monthly amount drifted -2.90%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Johnson & Johnson [NYSE: JNJ] stock has seen the most recent analyst activity on May 13, 2025, when Leerink Partners downgraded its rating to a Market Perform but kept the price target unchanged to $153 for it. On November 15, 2024, Wolfe Research initiated with a Outperform rating and assigned a price target of $190 on the stock. Daiwa Securities downgraded its rating to a Neutral and decreased its price target to $150 on July 23, 2024. HSBC Securities upgraded its rating to Buy for this stock on April 18, 2024, but kept the price target unchanged to $170. In a note dated December 13, 2023, Wells Fargo downgraded an Equal Weight rating on this stock and revised its target price from $170 to $163.
Johnson & Johnson [JNJ] stock has fluctuated between $140.68 and $169.99 over the past year. Currently, Wall Street analysts expect the stock to reach $164 within the next 12 months. Johnson & Johnson [NYSE: JNJ] shares were valued at $153.18 at the most recent close of the market. An investor can expect a potential return of 7.06% based on the average JNJ price forecast.
Analyzing the JNJ fundamentals
Johnson & Johnson [NYSE:JNJ] reported sales of 89.33B for the trailing twelve months, which represents a growth of 2.39%. Gross Profit Margin for this corporation currently stands at 0.68% with Operating Profit Margin at 0.25%, Pretax Profit Margin comes in at 0.3%, and Net Profit Margin reading is 0.24%. To continue investigating profitability, this company’s Return on Assets is posted at 0.11, Equity is 0.3 and Total Capital is 0.16. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.67.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, Johnson & Johnson’s Current Ratio is 1.26. As well, the Quick Ratio is 1.03, while the Cash Ratio is 0.68. Considering the valuation of this stock, the price to sales ratio is 4.13, the price to book ratio is 4.72 and price to earnings (TTM) ratio is 17.03.
Transactions by insiders
Recent insider trading involved Decker Robert J, VP Corporate Controller, that happened on Feb 25 ’25 when 6999.0 shares were sold. Officer, Decker Robert J completed a deal on Feb 25 ’25 to buy 6999.0 shares. Meanwhile, EVP, WW Chair, MedTech Schmid Timothy sold 403.0 shares on Feb 18 ’25.
